Quick Answer
PharmaCyte Biotech, Inc. reported Earnings Per Share Diluted of $3.19 per share for the year ending 2025.
- PharmaCyte Biotech, Inc. showed an increase of +277.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on August 11, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), PharmaCyte Biotech, Inc.'s Earnings Per Share Diluted has grown by 230.2%.
- Historical annual values: Fiscal year 2025: $3.19 per share | Fiscal year 2024: $1.80 (loss) per share | Fiscal year 2023: $0.22 (loss) per share | Fiscal year 2022: $0.27 (loss) per share | Fiscal year 2021: $2.45 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: